Miami Valley Hospital is a large urban hospital in Dayton, Ohio, and is a member of the Premier Health Partners network. The hospital has two additional locations; Miami Valley Hospital South in Centerville, Ohio, and Miami Valley Hospital North in Englewood, Ohio.

There are 970 beds in Miami Valley Hospital.

During the past decade, Miami Valley Hospital conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 136 clinical trials were completed, i.e. on average, 97.1% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 61 clinical trials were completed. i.e. 138.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Miami Valley Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 151 trials, followed by "SWOG Cancer Research Network" with 37 trials sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored and "Gynecologic Oncology Group" with 20 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miami Valley Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 116 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 7 trials as a collaborator. Other collaborators include 143 different institutions and companies that were collaborators in the rest 122 trials.

According to Clinical.Site data, the most researched conditions in "Miami Valley Hospital" are "Recurrent Breast Carcinoma" (13 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Breast Cancer AJCC v6 and v7" (9 trials), "Cervical Adenocarcinoma" (8 trials) and "Invasive Breast Carcinoma" (8 trials). Many other conditions were trialed in "Miami Valley Hospital" in a lesser frequency.

Most popular intervention types in "Miami Valley Hospital" are "Drug" (257 trials), "Other" (171 trials), "Biological" (117 trials), "Procedure" (65 trials) and "Radiation" (30 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (99 trials), "Quality-of-Life Assessment" (63 trials), "Paclitaxel" (40 trials), "Carboplatin" (38 trials) and "Computed Tomography" (31 trials). Other intervention names were less common.

The vast majority of trials in "Miami Valley Hospital" are 240 trials for "All" genders, 63 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Miami Valley Hospital". undefined are not yet recruiting, 66 are recruiting, 115 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 97 completed trials in Miami Valley Hospital, 3 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Miami Valley Hospital, 9 "Phase 1" clinical trials were conducted, 145 "Phase 2" clinical trials and 151 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 14 trials that are defined as “Not Applicable".

Miami Valley Hospital has several departments that took part in Clinical trials: "Premier Cardiovascular Institute" - 5 trials, "Middletown Cardiovascular Associates" - 3 trials